41 results about "Tachypnea" patented technology

Techniques are provided for detecting the onset of an episode of apnea / hypopnea substantially in real-time. A moving threshold is generated based on recent respiration cycles and differences are accumulated between amplitudes of new respiration cycles and the moving threshold. Apnea / hypopnea is then detected based upon a comparison of the accumulated differences against a fixed threshold. The technique exploits the fact that many episodes of hypopnea begin with a sharp drop in respiration and many episodes of apnea are preceded by a sharp drop in respiration. By accumulating differences between new respiration amplitudes and a short term moving average, any sharp drop in respiration is thereby promptly detected. In many cases, by the time the amplitudes of individual respiration cycles drop to levels directly indicative of apnea / hypopnea, the episode of apnea / hypopnea will have already been detected based upon the sudden sharp drop in respiration amplitude and therapy will have already been initiated.

Patient respiration is sensed from which respiration measurements are made, including a median respiration rate (MedRR) and a maximum respiration rate (MaxRR). Determinations are made as to whether an abnormality exists in MedRR and in MaxRR. An output indicative of the patient's tachypnea status is generated in response to determining the abnormality in MedRR and MaxRR.

The present invention provides the use of ATP for the manufacture of a medicine for exerting a pharmacological effect when administered to a mammal, preferably a human, selected from the group consisting of: 1°. modulating inflammation by inhibiting the inflammatory response to a strong external insult such as endotoxin (LPS) and / or phytohaemagglutinin; 2°. exerting said inhibitory effect on inflammatory response to an external stimulus even under conditions of oxidative stress, 3°. exerting a local immuno-modulating and anti-inflammatory effect in the intestine, thus preventing intestinal damage induced by a non-steroid anti-inflammatory drug (NSAIDs), 4°. exerting an immuno-modulating and anti-inflammatory effect in human intestinal cells in vitro, 5°. alleviating pulmonary symptoms, such as shortness of breath and dyspnoea, in patients suffering from an obstructive pulmonary disease, and 6°. exerting favorable clinical effects with respect to certain mental and neurological disorders and aberrant conditions. The medicine is preferably manufactured in lyophilized form.

The invention relates to the technical field of medical apparatus and instruments, and discloses an anesthetization spraying device with a quantitative spraying function. The device comprises a shell;a collecting box is fixedly mounted at the top end in the shell; a first exhaust pipe is fixedly connected to the left side of the collecting box; a baffle is hinged to the bottom end in the collecting box; first contact switches are fixedly installed at the top end of the baffle and the inner wall of the collecting box; first springs are fixedly installed at the top end of the baffle and the inner wall of the collecting box; an air bag is fixedly connected to the output end of the collecting box through a hose; a fixed ring is placed on the outer side of the air bag; and four sliding rods arranged at equal intervals are connected to the interior of the fixed ring in a sliding manner. According to the device, the situation that in a ventilation process of a patient in an anesthetization process, atomized airflow interacts with gas exhaled out of the body of the patient, so that the pressure intensity of the patient in the ventilation process is relatively large and shortness of breathof the patient is caused is avoided; and real-time adjustment can be conveniently carried out according to the anesthetic gas demand of the patient.

A method for enhanced exercise training or performance utilizing intentional controlled tachypnea and somatic sensory alkalosis biofeedback training to maintain an essentially non-acidic state during exercise. A trainee is instructed to decrease measured transcutaneous CO2 levels by increased ventilation and to correlate measured transcutaneous CO2 levels with subjective somatic symptoms. Studies under exercise conditions measure the intensity of exercise correlating to an onset in blood acid accumulation in the trainee and such level of intensity is in turn correlated with a predetermined heart rate. The trainee is then instructed to use heart rate and somatic sensory changes as a guide to the need for increased ventilation to lower blood CO2. In another embodiment, the method of the instant invention utilizes intentional controlled tachypnea to increase maximum breath holding time.

The invention provides a formula of agarwood and a preparation method of the agarwood. The agarwood consists of 50%-60% of agarwood powder, 18%-23% of nanmu powder and 20%-30% of traditional Chinese medicine powder. The preparation method of the agarwood comprises the following steps: (1), respectively placing the agarwood, the nanmu and each component of the traditional Chinese medicine into a grinder for grinding for 1 hour-1.5 hours after drying the agarwood, the nanmu and each component of the traditional Chinese medicine, and preparing each material powder after each material is grinded and respectively passes through a 50-300-mesh sieve; (2), mixing the prepared each material powder according to each material proportion, and then uniformly mixing to obtain agarwood spice; and (3), pressing and forming the prepared agarwood spice by a mould to obtain finished product agarwood. The agarwood prepared by the special components in a special proportion is elegant, rich and full, and fresh in flavor; smell emitted by burning the agarwood can be used for purifying air, decomposing passive smoking, and has auxiliary treatment effects for deficiency of kidney-yang, reversed flow of qi and tachypnea, epicophosis due to large intestine deficiency, stranguria due to disturbance of qi, and essence-enriching yang-tonifying.

The invention discloses an intermittent atomization inhaler for infants. The atomization inhaler comprises an atomization body, an inhaling pipe, a liquid medicine bottle and a contact controller, wherein the atomization body is controlled by virtue of the contact controller; the liquid medicine bottle is connected with the atomization body by virtue of a rotary fixator; a liquid medicine flow controller is arranged on the atomization body; one end of the inhaling pipe is connected with the atomization body, and the other end of the inhaling pipe is provided with an inhaling hood which is a nipple type inhaling hood; and the outlet diameter of the front end of the nipple type inhaling hood is 0.8-1.5cm. The atomization inhaler can be used for preventing an infant from resisting the atomization inhaler since the infant inhales atomized liquid through the nipple type inhaling hood, has intermittent performance to prevent tachypnea and other diseases and atomization drug waste caused by imbalanced inhaled air in the atomization treatment process, and is suitable for all infants requiring atomization treatment.

The invention is related to a portable rebreathing system for closed rebreathing. In order to minimize consumption of oxygen during rebreathing mode while safeguarding correct oxygen concentration, oxygen is added into the breathing passage using staged addition of oxygen via at least three individual oxygen supply valves 51, 52, 53. The two first oxygen supply valves are calibrated nozzles where one nozzle 51 is constantly delivering a predetermined amount of oxygen during normal breathing and the second nozzle 52 adds more oxygen at a second predetermined amount when the person to be treated is breathing heavily. The third valve is only opened manually and delivers a short burst of oxygen that fills the rebreathing system and its counter lung within seconds.

The present invention relates to a method for differentiating in a subject suffering from acute shortness of breath (dyspnea) between (i) a pulmonary disease, (ii) a cardiovascular complication, (iii) a cardiovascular complication accompanied by a pulmonary disease or (iv) acute dyspnea without cardiovascular or pulmonary causes comprising the steps of determining the amount of pulmonary surfactant protein B (SP-B) in a sample of a subject, determining the amount of N-terminal pro-brain natriuretic peptide (NT-proBNP) in a sample of the subject, and differentiating between (i) a pulmonary disease, (ii) a cardiovascular complication, (iii) a cardiovascular complication accompanied by a pulmonary disease or (iv) acute dyspnea without cardiovascular or pulmonary causes by comparing the determined amounts with reference amounts.

The present invention provides a use of a HIF-2alpha inhibitor in preparation of drugs for preventing and treating acute high-altitude reaction. The HIF-2alpha inhibitor comprises HIF-2alpha-I2 and / orPT2385; the use according to the invention fully investigates molecular mechanisms and key molecular events and processes of acute high-altitude reaction and hypoxia stress, and a series of experiments shows that HIF-2alpha-I2 and PT2385 both can significantly improve the malignant degree and symptoms including slowing shortness of breath, emotional upset, and high heart rate of acute high-altitude reaction, as well as alleviate the acute hypoxic stress response, so as to achieve the purpose of effectively preventing acute hypoxia. The use has good safety, little side effects and other advantages, and has a good application prospect.

The invention relates to the technical field of medicines and in particular relates to application of a triterpenoid saponins compound. The invention provides application of the triterpenoid saponins compound with a structure formula I to preparation of a medicine for treating asthma. An experiment testifies that the triterpenoid saponins compound with the structure formula I has an obvious inhibition effect on a platelet activating factor receptor and can be used for alleviating tachypnea and accelerated frequency, caused by the asthma, and remarkably reducing the amount of Eos (Eosinophile granulocyte) in rat blood and reducing infiltration on trachea by the Eos; meanwhile, the secretion of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) in BALF (Bronchoalveolar Lavage Fluid) of guinea pigs can be inhibited and a PAF (Platelet-Activating Factor) level of blood serum of the guinea pigs is remarkably reduced, and the activation of inflammatory cells and the releasing of inflammatory transmitters are stopped, so that inflammation of the trachea is alleviated and smooth muscles of bronchus are relaxed; the high responsiveness of the trachea is reduced to treat the asthma, so that the triterpenoid saponins compound has the effect of treating the asthma and application value.

The invention discloses an exercise muscle respiration scoring method, which comprises the steps of: (1) recording a somatosensory state when a human body exercises, wherein the somatosensory state comprises a shortness degree of breath of the human body and a fatigue degree of muscles of the human body; (2) quantifying the shortness degree of breath of the human body by using a borg breath shortness scale to obtain a breath shortness degree quantified score, quantifying the fatigue degree of the muscles of the human body to obtain a muscle fatigue degree quantified score, and combining the breath shortness degree quantified score with the muscle fatigue degree quantified score to obtain an exercise muscle respiration quantified comprehensive score; (3) determining a human body exercise comfort zone according to the exercise muscle respiration quantified comprehensive score, and judging an early-warning level; (4) and analyzing causes of discomfort of human body exercise according to the human body exercise comfort zone. The exercise muscle respiration scoring method can provide dyspnea assessment while completing muscle fatigue assessment simultaneously, can play an excellent rolein evaluating conditions of the human body in exercise, improves the applicability and precision of evaluation results, and is of great significance to reducing the occurrence of exercise risks.

The invention discloses a traditional Chinese medicine electuary for treating infantile pneumonia and a preparation method of the traditional Chinese medicine electuary. The traditional Chinese medicine electuary is prepared from the following traditional Chinese medicinal materials in parts by weight: 25-35 parts of fagopyrum dibotrys, 20-30 parts of sowthistle tasselflower herb, 20-30 parts of affine cudweeds, 15-25 parts of Chinese yam,15-25 parts of houttuynia cordata, 15-25 parts of muskmelon seeds, 10-20 parts of senecio scandens, 10-20 parts of common nightblooming cereus, 5-15 parts of snakegourd fruits, 5-15 parts of gingko leaves, 2-8 parts of liquorice, 2-8 parts of platycodon grandiflorum and 2-8 parts of loquat leaves. Common traditional Chinese medicines are adopted as the raw materials, the traditional Chinese medicine electuary for treating infantile pneumonia is scientific in formula, low in cost, significant in curative effect and free of side effect, has the efficacies of clearing away heat and toxic materials, clearing heat, dissipating phlegm, relieving cough and asthma, benefiting the lung and removing dampness, and is capable of effectively treating the symptoms of a fever, a cough, polypnea, dyspnea, lung rale and the like.

The invention discloses an anesthetic gas flow adjusting system which comprises anesthetic gas generating equipment, a flow adjusting module, a flow blocking module, an oxygen confluence module and an anesthetic breathing mask, and the anesthetic gas generating equipment, the flow adjusting module, the flow blocking module and the oxygen confluence module are sequentially communicated through anesthetic pipelines. A blocking plug, an expiration recovery pipe and a timer are arranged on the inner side of the flow blocking module, a movement limiting assembly is arranged on the left side of the blocking plug, an electromagnetic telescopic rod piece is arranged below the movement limiting assembly, an automatic limiting module is arranged at one end of the electromagnetic telescopic rod piece, an oxygen supply pipe is arranged at the top end of the oxygen confluence module, and a flow control module is arranged at the top end of the oxygen confluence module. According to the oxygen supply device, the flow of anesthetic gas is reduced when a patient is tachypnea, the situation that the elderly patient inhales excessive anesthetic gas due to tachypnea caused by diseases of the elderly patient is avoided, oxygen is supplied through the two oxygen supply pipes, the oxygen supply amount of the patient is increased, and the hypoxia condition of the patient is slowed down.

The invention relates to a pharmaceutical composition for treating bronchial asthma and a preparation method of the pharmaceutical composition, belonging to the field of the traditional Chinese medicine. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 380-420 parts of Chinese ephedra, 380-420 parts of fried bitter apricot kernel, 350-370 parts of blackberry lily and 110-130 parts of asarum. The composition in the invention is capable of warming lung and dispelling cold, resolving sputum and relieving asthma; and the composition is used for treating the asthma, and the symptoms such as tachypnea, wheezing with sound in throat and choking sensation in chest and the like; and the composition is mainly used for treating the asthma caused by coldness.

An appliance for relieving tachypnea of an infant belongs to the technical field of medical devices. When treated in a hospital, the infant possibly has tachypnea syndrome due to pain caused by the fear and the illness state of the infant, a medical worker often slightly covers an oral area of the infant with a hand to adjust the amount of inhaled carbon dioxide gas in order to eliminate the syndrome, the infant is possibly more frightened by the operation process, and the hand of the medical worker is contaminated. The technical scheme of the appliance includes that a lower end opening of a flare tube (1) is communicated with a silicon rubber gasket (6) in a fixedly connected manner, an upper end opening of the flare tube (1) is communicated with a thin straight tube (2) in a fixedly connected manner, a small-diameter end opening (4) is arranged at an upper end opening of the thin straight tube (2), a large-diameter end opening (5) is arranged at a lower end opening of the silicon rubber gasket (6), and a damper switch (3) is mounted on the thin straight tube (2). The appliance has the advantages that the appliance is simple and convenient in operation, time and labor are saved, and medical efficiency is greatly improved.

The invention relates to the technical field of medical devices, and discloses a spray device for anesthesia that can be sprayed quantitatively, including a casing, a collection box is fixedly installed at the top of the casing, and a first Exhaust pipe, the internal bottom of the collection box is hinged with a baffle, the top of the baffle and the inner wall of the collection box are fixedly equipped with a first contact switch, the top of the baffle and the inner wall of the collection box are fixed The first spring is installed, the output end of the collection box is fixedly connected with an air bag through a hose, a fixed ring is placed on the outside of the air bag, and four equidistantly arranged slide bars are slidably connected inside the fixed ring. The invention will not cause the patient's shortness of breath due to the interaction between the atomized airflow and the exhaled gas in the patient's body during the anesthesia process, and it is convenient to carry out according to the patient's demand for anesthesia gas. Adjust in real time.

The invention discloses a head-mounted face sauna device capable of spraying atomized essence. The head-mounted face sauna device comprises a head ring worn on the head and a neck wearing ring hung onthe neck, wherein a semicircular steam hole is formed in the neck wearing ring; nine vertically-through steam outlet holes are uniformly distributed in the upper side of the semicircular steam hole;a lower fan-shaped groove with an upward opening is formed in the front upper end of the neck wearing ring; a lower sliding block is arranged in the lower fan-shaped groove in a sliding manner; according to the invention, sauna beautifying can be carried out on the face; compared with traditional sauna, the problem of difficulty in tachypnea during sauna can be solved; the whole device is small insize and convenient to store at home, essence needs to be supplemented and beautified after traditional sauna is finished, the essence can be evenly sprayed to the whole face, the problem that the essence is not evenly smeared manually is solved, the atomized essence can be absorbed by the skin more conveniently, and the beautifying effect can be improved.

An oxygen inhalation device for relieving tachypnea of an infant suffering from a congenital heart disease belongs to the technical field of medical devices. When treated, the infant suffering from the congenital heart disease possibly has tachypnea syndrome due to pain caused by the fear and the illness state of the infant, a medical worker often slightly covers an oral area of the infant with a hand to adjust the amount of inhaled carbon dioxide gas in order to eliminate the syndrome, the infant is possibly more frightened by the operation process, and even the life of the infant is threatened. The technical scheme of the oxygen inhalation device includes that an oxygen inlet plug tube (9) with a switch (10) is communicated with a flare tube (1) in a fixedly connected manner, a low end opening of the flare tube (1) is communicated with a silicon rubber gasket (6) in a fixedly connected manner, an upper end opening of the flare tube (1) is communicated with a thin straight tube (2) in a fixedly connected manner, and a small-diameter end opening (4) is arranged at an upper end opening of the thin straight tube (2). The oxygen inhalation device has the advantages that the device has complete design functions, the infant suffering from the congenital heart disease can be treated in a composite manner, and medical rescue efficiency is greatly improved.

The invention relates to equipment for alleviating children tachypnea, which belongs to the technical field of medical equipment. When seeing a doctor in a hospital, a child may have a tachypnea syndrome due to discomfort caused by fear and illness, for eliminating the symptom, medical workers use their hands to gently cover the mouth of the child to adjust the amount of inhaled carbon dioxide gas, so as to well control the pH value of the respiratory system of child, wherein the operation process may cause more fear of the child and even endanger the life of the child. The technical scheme of the invention is as follows: a flared pipe (1) is fixedly connected and communicated with a fine straight pipe (2), a small-diameter port (4) is arranged on the upper port of the fine straight pipe (2), a large-diameter port (5) is arranged on the lower port of the flared pipe (1), and two belt ropes tied in front are respectively fixedly connected with the port with large diameter (5). The equipment for alleviating children tachypnea can effectively eliminate children tachypnea symptom, and is beneficial for children patients, easy and convenient to operate, and time-saving and labor-saving, so that the treatment efficiency is greatly improved.

The invention discloses a traditional Chinese medicine preparation for treating anxiety and a preparation method thereof, which belong to the field of traditional Chinese medicines; the raw materials of the active ingredients of the traditional Chinese medicine preparation of the invention are composed of: firework, hydrangea, stone dragon cud, licorice, acacia bark, eucommia, Variegated leaf orchid, scutellaria baicalensis, rose root, polygala, Pu Songshi, valerian, sun needle, pomelo peel, huixincao and Guangzao; Stagnation, Lishui Tonglin, reconcile various medicines, nourishing kidney and Qi, clearing heat and purging fire, calming and improving intelligence, etc. The combination of all medicines can directly reach the lesion site, and is effective for treating anxiety-induced palpitations, frequent urination, restlessness, dizziness, chest tightness, and palpitation Symptoms such as shortness of breath, sweating, and trembling all over the body have the advantages of quick results, high cure rate, no toxic and side effects, safety and convenience, and are cheap and easy to prepare.

The invention relates to a device for relieving tachypnea of children with a congenital heart disease, belonging to the technical field of medical devices. When some children with the congenital heart disease see a doctor treating the case, the children probably generate tachypnea syndrome due to fear and pain caused by illness; in order to eliminate the symptom, medical workers always gently cover the mouth to regulate the quantity of inspired carbon dioxide gas; and the operation process probably causes the children with the congenital heart disease to be more scared or threatens the life. The technical scheme of the device is that: the lower port of a horn tube (1) is fixedly connected and communicated with a silicone rubber washer (6), and the upper port of the horn tube (1) is fixedly connected and communicated with a fine straight tube (2); the upper port of the fine straight tube (2) is provided with a small-diameter port (4); and the lower port of the silicone rubber washer (6) is provided with a large-diameter port (5). The device has the advantages that the tachypnea symptom of children can be effectively eliminated, and the device is beneficial to the children with the congenital heart disease; the device is simply and conveniently operated, and the time and labor are saved; and the treatment efficiency is greatly increased.

The invention relates to an oxygen inhalation device relieving shortness of breath of a child with congenital heart disease, which belongs to the technical field of medical equipment. A child with congenital heart disease, who seeks for medical help in a hospital, may have tachypnea syndrome due to discomfort caused by fear and illness, in order to eliminate the symptom, medical workers always use hands to gently cover the mouth of the child, in which the child may be further fear. The technical scheme of the invention is as follows: an oxygen inlet plug pipe (9) with a switch (8) is fixedly connected and communicated with a flared pipe (1), the flared pipe (1) is fixedly connected and communicated with a fine straight pipe (2), a small-diameter port (4) is arranged on the upper port of the fine straight pipe (2), a large-diameter port (5) is arranged on the lower port of the flared pipe (1), a front rubber belt lantern ring (6) and a rear rubber belt lantern ring are both fixedly connected with the large-diameter port (5), and an air door switch (3) is installed on the fine straight pipe (2). The oxygen inhalation device of the invention is easy and convenient to operate, and is time-saving and labor-saving, and greatly improves medical treatment efficiency.

The invention discloses a novel use of deacidized type glutathione (GSH) in the field of pharmacy, which can be applied for the treatment of systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS), and has the effects of suppression of body temperature rapid decrease, lowering tachypnea and respiratory distress, intensifying leucocyte number, and alleviating heart rate quickening.

The invention discloses a device for alleviating tachypnea of children, which relates to the technical field of the device for alleviating tachypnea of children, which solves the problems of effectively alleviating tachypnea of children, improving the treatment environment to make the treatment effect good, and can be used for multiple functions. The device includes a main body, a control device is installed at one end of the main body, and two sides of the lower end of the control device are provided with broadcasting holes, an air outlet is installed on one end of the control device, a dustproof plate is installed on the upper end surface of the air outlet, and two connection holes are installed on both sides of the air outlet. An atomizing tube is installed inside the lower end of the connection holes, an atomizer is installed at the lower end of the atomizing tube, a feeding tube is installed at one end of the atomizer, and a sealing door is installed at the upper end of the feeding tube. The device effectively relieves the tachypnea of children, improves the treatment environment and makes the treatment effect good, and can be used for multiple functions.

The portable first-aid breathing bag comprises a connector, a Y-shaped pipe, a threaded pipe, a rubber balloon and an air valve, the connector is detachably connected with the Y-shaped pipe through threads, the lower end of the Y-shaped pipe is detachably connected with the threaded pipe, the lower end of the threaded pipe is detachably connected with the rubber balloon, and the air valve is installed at the tail end of the rubber balloon. The emergency oxygen supply device can quickly supply oxygen to a patient in emergency, and is convenient to carry and simple to operate; an oxygen supply device is connected, so that oxygen can be continuously supplied to a patient; the internal examination port is arranged, so that sputum suction, gastroscope, bronchofiberscope and other internal examinations can be carried out on the premise of not influencing ventilation; the sealing degree of the air valve can be freely adjusted between 0% and 100%, corresponding adjustment can be conveniently carried out according to patients with different illness states, carbon dioxide is supplemented in time for the patients with tachypnea, and complications are avoided; meanwhile, the device is suitable for adults and children and can be used for breathing extubation transition and observation of postoperative resuscitation of general anesthesia patients.

The invention relates to the technical field of medicines and in particular relates to application of a triterpenoid saponins compound. The invention provides application of the triterpenoid saponins compound with a structure formula I to preparation of a medicine for treating asthma. An experiment testifies that the triterpenoid saponins compound with the structure formula I has an obvious inhibition effect on a platelet activating factor receptor and can be used for alleviating tachypnea and accelerated frequency, caused by the asthma, and remarkably reducing the amount of Eos (Eosinophile granulocyte) in rat blood and reducing infiltration on trachea by the Eos; meanwhile, the secretion of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) in BALF (Bronchoalveolar Lavage Fluid) of guinea pigs can be inhibited and a PAF (Platelet-Activating Factor) level of blood serum of the guinea pigs is remarkably reduced, and the activation of inflammatory cells and the releasing of inflammatory transmitters are stopped, so that inflammation of the trachea is alleviated and smooth muscles of bronchus are relaxed; the high responsiveness of the trachea is reduced to treat the asthma, so that the triterpenoid saponins compound has the effect of treating the asthma and application value.